1
|
Mawick M, Jaworski C, Bittermann J, Iovkova L, Pu Y, Wängler C, Wängler B, Jurkschat K, Krause N, Schirrmacher R. CycloSiFA: The Next Generation of Silicon-Based Fluoride Acceptors for Positron Emission Tomography (PET). Angew Chem Int Ed Engl 2023; 62:e202309002. [PMID: 37850849 DOI: 10.1002/anie.202309002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Revised: 10/12/2023] [Accepted: 10/17/2023] [Indexed: 10/19/2023]
Abstract
The ring-opening Si-fluorination of a variety of azasilole derivatives cyclo-1-(iPr2 Si)-4-X-C6 H3 -2-CH2 NR (4: R=2,6-iPr2 C6 H3 , X=H; 4 a: R=2,4,6-Me3 C6 H2 , X=H; 9: R=2,6-iPr2 C6 H3 , X=tBuMe2 SiO; 10: R=2,6-iPr2 C6 H3 , X=OH; 13: R=2,6-iPr2 C6 H3 , X=HCCCH2 O; 22: R=2,6-iPr2 C6 H3 , X=tBuMe2 SiCH2 O) with different 19 F-fluoride sources was studied, optimized and the experience gained was used in a translational approach to create a straightforward 18 F-labelling protocol for the azasilole derivatives [18 F]6 and [18 F]14. The latter constitutes a potential clickable CycloSiFA prosthetic group which might be used in PET tracer development using Cu-catalysed triazole formation. Based on our findings, CycloSiFA has the potential to become a new entry into non-canonical labelling methodologies for radioactive PET tracer development.
Collapse
Affiliation(s)
- Matthias Mawick
- Fakultät für Chemie und Chemische Biologie, Lehrstuhl für Organische Chemie, Technische Universität Dortmund, Otto-Hahn-Straße 6, 44227, Dortmund, Germany
| | - Carolin Jaworski
- Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB T6G 1Z2, Canada
| | - Jens Bittermann
- Fakultät für Chemie und Chemische Biologie, Lehrstuhl für Organische Chemie, Technische Universität Dortmund, Otto-Hahn-Straße 6, 44227, Dortmund, Germany
| | - Ljuba Iovkova
- Fakultät für Chemie und Chemische Biologie, Lehrstuhl für Organische Chemie, Technische Universität Dortmund, Otto-Hahn-Straße 6, 44227, Dortmund, Germany
| | - Yinglan Pu
- Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB T6G 1Z2, Canada
| | - Carmen Wängler
- Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - Björn Wängler
- Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - Klaus Jurkschat
- Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Otto-Hahn-Straße 6, 44227, Dortmund, Germany
| | - Norbert Krause
- Fakultät für Chemie und Chemische Biologie, Lehrstuhl für Organische Chemie, Technische Universität Dortmund, Otto-Hahn-Straße 6, 44227, Dortmund, Germany
| | - Ralf Schirrmacher
- Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB T6G 1Z2, Canada
| |
Collapse
|
2
|
King AT, Matesic L, Keaveney ST, Jamie JF. An Investigation into the In Vitro Metabolic Stability of Aryl Sulfonyl Fluorides for their Application in Medicinal Chemistry and Radiochemistry. Mol Pharm 2023; 20:1061-1071. [PMID: 36638322 DOI: 10.1021/acs.molpharmaceut.2c00806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Molecules that feature a sulfonyl fluoride (SO2F) moiety have been gaining increasing interest due to their unique reactivity and potential applications in synthetic chemistry, medicinal chemistry, and other biological uses. A particular interest is towards 18F-radiochemistry where sulfonyl fluorides can be used as a method to radiolabel biomolecules or can be used as radiofluoride relay reagents that facilitate radiolabeling of other molecules. The low metabolic stability of sulfonyl fluoride S-F bonds, however, presents an issue and limits the applicability of sulfonyl fluorides. The aim of this work was to increase understanding of what features contribute to the metabolic instability of the S-F bond in model aryl sulfonyl fluorides and identify approaches to increasing sulfonyl fluoride stability for 18F-radiochemistry and other medicinal, synthetic chemistry and biological applications. To undertake this, 14 model aryl sulfonyl fluorides compounds with varying functional groups and substitution patterns were investigated, and their stabilities were examined in various media, including phosphate-buffered saline and rat serum as a model for biological conditions. The results indicate that both electronic and steric factors affect the stability of the S-F bond, with the 2,4,6-trisubstituted model aryl sulfonyl fluorides examined displaying the highest in vitro metabolic stability.
Collapse
Affiliation(s)
- Andrew T King
- School of Natural Sciences, Wallumattagal Campus, Macquarie University, North Ryde, New South Wales 2109, Australia
| | - Lidia Matesic
- Australian Nuclear Science and Technology Organisation, New Illawarra Rd, Lucas Heights, New South Wales 2234, Australia
| | - Sinead T Keaveney
- School of Natural Sciences, Wallumattagal Campus, Macquarie University, North Ryde, New South Wales 2109, Australia.,School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales 2522, Australia
| | - Joanne F Jamie
- School of Natural Sciences, Wallumattagal Campus, Macquarie University, North Ryde, New South Wales 2109, Australia
| |
Collapse
|
3
|
Scroggie KR, Perkins MV, Chalker JM. Reaction of [ 18F]Fluoride at Heteroatoms and Metals for Imaging of Peptides and Proteins by Positron Emission Tomography. Front Chem 2021; 9:687678. [PMID: 34249861 PMCID: PMC8262615 DOI: 10.3389/fchem.2021.687678] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Accepted: 06/07/2021] [Indexed: 12/11/2022] Open
Abstract
The ability to radiolabel proteins with [18F]fluoride enables the use of positron emission tomography (PET) for the early detection, staging and diagnosis of disease. The direct fluorination of native proteins through C-F bond formation is, however, a difficult task. The aqueous environments required by proteins severely hampers fluorination yields while the dry, organic solvents that promote nucleophilic fluorination can denature proteins. To circumvent these issues, indirect fluorination methods making use of prosthetic groups that are first fluorinated and then conjugated to a protein have become commonplace. But, when it comes to the radiofluorination of proteins, these indirect methods are not always suited to the short half-life of the fluorine-18 radionuclide (110 min). This review explores radiofluorination through bond formation with fluoride at boron, metal complexes, silicon, phosphorus and sulfur. The potential for these techniques to be used for the direct, aqueous radiolabeling of proteins with [18F]fluoride is discussed.
Collapse
Affiliation(s)
| | | | - Justin M. Chalker
- Institute for Nanoscale Science and Technology, College of Science and Engineering, Flinders University, Adelaide, SA, Australia
| |
Collapse
|
4
|
Otaru S, Niemikoski H, Sarparanta M, Airaksinen AJ. Metabolism of a Bioorthogonal PET Tracer Candidate [ 19F/ 18F]SiFA-Tetrazine in Mouse Liver Microsomes: Biotransformation Pathways and Defluorination Investigated by UHPLC-HRMS. Mol Pharm 2020; 17:3106-3115. [PMID: 32539414 PMCID: PMC7497667 DOI: 10.1021/acs.molpharmaceut.0c00523] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
![]()
Organofluorosilicon based 18F-radiolabeling is an efficient
method for incorporating fluorine-18 into 18F-radiopharmaceuticals
for positron emission tomography (PET) by 19F/18F isotopic exchange (IE). The first PET radiopharmaceutical, 18F-SiFAlin-TATE, radiolabeled with a silicon-based
[18F]fluoride acceptor (SiFA), namely, a para-substituted
di-tert-butyl[18F]fluorosilylbenzene,
has entered clinical trials, and is paving the way for other potential
[18F]SiFA-labeled radiopharmaceuticals for diagnostic use.
In this study, we report the in vitro metabolism
of an oxime-linked SiFA tetrazine (SiFA–Tz), a new PET-radiotracer
candidate, recently evaluated for pretargeted PET imaging and macromolecule
labeling. Metabolism of SiFA–Tz was studied in mouse liver
microsomes (MLM) for elucidating its major biotransformation pathways.
Nontargeted screening by ultrahigh performance liquid chromatography
high-resolution mass spectrometry (UHPLC-HRMS) was utilized for detection
of unknown metabolites. The oxime bond between the SiFA and Tz groups
forms two geometric (E/Z) isomers,
which underwent the same biotransformations, but unexpectedly with
different kinetics. In total, nine proposed metabolites of SiFA–Tz
from phase I and II reactions were detected, five of which were defluorinated
in MLMs, elucidating the metabolic pathway leading to previously reported
defluorination of [18F]SiFA–Tz in vivo. Based on the HRMS studies a biotransformation pathway is proposed:
hydroxylation (+O) to tert-butyl group adjacent to
the silicon, followed by oxidative defluorination (+OH/-F) cleaving
the fluorine off the silicon. Interestingly, eight proposed metabolites
of a reduced dihydrotetrazine analogue, SiFA–H2Tz,
from phase I and II reactions were additionally detected. To the best
of our knowledge, this is the first reported comprehensive investigation
of enzyme mediated metabolic pathway of tetrazines and para-substituted
di-tert-butylfluorosilylbenzene fluoride acceptors,
providing novel structural information on the biotransformation and
fragmentation patterns of radiotracers bearing these structural motifs.
By investigating the metabolism preceding defluorination, structurally
optimized new SiFA compounds can be designed for expanding the portfolio
of efficient 19F/18F isotopic exchange labeling
probes for PET imaging.
Collapse
Affiliation(s)
- Sofia Otaru
- Radiochemistry, Department of Chemistry, University of Helsinki, 00014 Helsinki, Finland
| | - Hanna Niemikoski
- Finnish Institute for Verification of the Chemical Weapons Convention (VERIFIN), Department of Chemistry, University of Helsinki, 00014 Helsinki, Finland
| | - Mirkka Sarparanta
- Radiochemistry, Department of Chemistry, University of Helsinki, 00014 Helsinki, Finland
| | - Anu J Airaksinen
- Radiochemistry, Department of Chemistry, University of Helsinki, 00014 Helsinki, Finland.,Turku PET Centre, Department of Chemistry, University of Turku, 20500 Turku, Finland
| |
Collapse
|
5
|
Miller EM, Walczak MA. Copper-Catalyzed Oxidative Acetalization of Boronic Esters: An Umpolung Strategy for Cyclic Acetal Synthesis. J Org Chem 2020; 85:8230-8239. [PMID: 32370495 DOI: 10.1021/acs.joc.0c00720] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
A protocol for the acetalization of boronic esters is described. The reaction is catalyzed by copper, and the conditions proved to be mild and were amenable to a variety of functional groups. We expanded the Chan-Lam coupling to include C(sp3) nucleophiles and converted them into corresponding acetals. This method allows for the orthogonal acetalization of substrates with reactive, acid-sensitive functional groups.
Collapse
Affiliation(s)
- Eric M Miller
- Department of Chemistry, University of Colorado, Boulder, Colorado 80309, United States
| | - Maciej A Walczak
- Department of Chemistry, University of Colorado, Boulder, Colorado 80309, United States
| |
Collapse
|
6
|
Wurzer A, Di Carlo D, Schmidt A, Beck R, Eiber M, Schwaiger M, Wester HJ. Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors. J Nucl Med 2020; 61:735-742. [PMID: 31862804 PMCID: PMC7198388 DOI: 10.2967/jnumed.119.234922] [Citation(s) in RCA: 73] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2019] [Accepted: 09/27/2019] [Indexed: 11/16/2022] Open
Abstract
When we critically assess the reason for the current dominance of 68Ga-labeled peptides and peptide-like ligands in radiopharmacy and nuclear medicine, we have to conclude that the major advantage of such radiopharmaceuticals is the apparent lack of suitable 18F-labeling technologies with proven clinical relevance. To prepare and to subsequently perform a clinical proof-of-concept study on the general suitability of silicon-fluoride-acceptor (SiFA)-conjugated radiopharmaceuticals, we developed inhibitors of the prostate-specific membrane antigen (PSMA) that are labeled by isotopic exchange (IE). To compensate for the pronounced lipophilicity of the SiFA unit, we used metal chelates, conjugated in close proximity to SiFA. Six different radiohybrid PSMA ligands (rhPSMA ligands) were evaluated and compared with the commonly used 18F-PSMA inhibitors 18F-DCFPyL and 18F-PSMA-1007. Methods: All inhibitors were synthesized by solid-phase peptide synthesis. Human serum albumin binding was measured by affinity high-performance liquid chromatography, whereas the lipophilicity of each tracer was determined by the n-octanol/buffer method. In vitro studies (IC50, internalization) were performed on LNCaP cells. Biodistribution studies were conducted on LNCaP tumor-bearing male CB-17 SCID mice. Results: On the laboratory scale (starting activities, 0.2-9.0 GBq), labeling of 18F-rhPSMA-5 to -10 by IE was completed in < 20 min (radiochemical yields, 58% ± 9%; radiochemical purity, >97%) with molar activities of 12-60 GBq/μmol. All rhPSMAs showed low nanomolar affinity and high internalization by PSMA-expressing cells when compared with the reference radiopharmaceuticals, medium-to-low lipophilicity, and high human serum albumin binding. Biodistribution studies in LNCaP tumor-bearing mice revealed high tumor uptake, sufficiently fast clearance kinetics from blood, low hepatobiliary excretion, fast renal excretion, and very low uptake of 18F activity in bone. Conclusion: The novel 18F-rhPSMA radiopharmaceuticals developed under the radiohybrid concept show equal or better targeting characteristics than the established 18F-PSMA tracers 18F-DCFPyL and 18F-PSMA-1007. The unparalleled simplicity of production, the possibility to produce the identical 68Ga-labeled 19F-68Ga-rhPSMA tracers, and the possibility to extend this concept to true theranostic radiohybrid radiopharmaceuticals, such as F-Lu-rhPSMA, are unique features of these radiopharmaceuticals.
Collapse
Affiliation(s)
- Alexander Wurzer
- Chair of Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany; and
| | - Daniel Di Carlo
- Chair of Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany; and
| | - Alexander Schmidt
- Chair of Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany; and
| | - Roswitha Beck
- Chair of Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany; and
| | - Matthias Eiber
- Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - Markus Schwaiger
- Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - Hans-Jürgen Wester
- Chair of Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany; and
| |
Collapse
|
7
|
Tisseraud M, Schulz J, Vimont D, Berlande M, Fernandez P, Hermange P, Fouquet E. Highly hindered 2-(aryl-di-tert-butylsilyl)-N-methyl-imidazoles: a new tool for the aqueous 19F- and 18F-fluorination of biomolecule-based structures. Chem Commun (Camb) 2018; 54:5098-5101. [PMID: 29714374 DOI: 10.1039/c8cc01782d] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
A new class of silicon-based fluoride acceptors with a C-linked heterocycle as the leaving group was synthesized in one step from commercial chemicals, and linked to biomolecules. The resulting conjugates were efficiently 19F-fluorinated in aqueous mixtures, and switching to 18F-labelling provided nucleoside- and peptide-based bioconjugates with excellent molar activities suitable for biological applications.
Collapse
Affiliation(s)
- Marion Tisseraud
- Univ. Bordeaux, Institut des Sciences Moléculaires, UMR-CNRS 5255, 351 Cours de la Libération, 33405 Talence Cedex, France.
| | | | | | | | | | | | | |
Collapse
|
8
|
Scroggie KR, Alcock LJ, Matos MJ, Bernardes GJL, Perkins MV, Chalker JM. A silicon‐labelled amino acid suitable for late‐stage fluorination and unexpected oxidative cleavage reactions in the preparation of a key intermediate in the Strecker synthesis. Pept Sci (Hoboken) 2018. [DOI: 10.1002/pep2.24069] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Kymberley R. Scroggie
- Flinders University, College of Science and EngineeringSouth Australia5042 Australia
| | - Lisa J. Alcock
- Flinders University, College of Science and EngineeringSouth Australia5042 Australia
| | - Maria J. Matos
- Department of ChemistryUniversity of CambridgeCambridgeCB2 1EW United Kingdom
| | - Gonçalo J. L. Bernardes
- Department of ChemistryUniversity of CambridgeCambridgeCB2 1EW United Kingdom
- Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas MonizInstituto de Medicina MolecularLisboa1649‐028 Portugal
| | - Michael V. Perkins
- Flinders University, College of Science and EngineeringSouth Australia5042 Australia
| | - Justin M. Chalker
- Flinders University, College of Science and EngineeringSouth Australia5042 Australia
| |
Collapse
|
9
|
Rugeri B, Audi H, Jewula P, Koudih R, Malacea-Kabbara R, Vimont D, Schulz J, Fernandez P, Jugé S. Designing Silylatedl-Amino Acids using a Wittig Strategy: Synthesis of Peptide Derivatives and18F-Labelling. European J Org Chem 2017. [DOI: 10.1002/ejoc.201701170] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Baptiste Rugeri
- Institut de Chimie Moléculaire de l'Université de Bourgogne-Franche-Comté; ICMUB-OCS (UMR CNRS 6302); 19 avenue A. Savary BP 47870 21078 Dijon CEDEX France
| | - Hassib Audi
- Institut de Chimie Moléculaire de l'Université de Bourgogne-Franche-Comté; ICMUB-OCS (UMR CNRS 6302); 19 avenue A. Savary BP 47870 21078 Dijon CEDEX France
| | - Pawel Jewula
- Institut de Chimie Moléculaire de l'Université de Bourgogne-Franche-Comté; ICMUB-OCS (UMR CNRS 6302); 19 avenue A. Savary BP 47870 21078 Dijon CEDEX France
| | - Radouane Koudih
- Institut de Chimie Moléculaire de l'Université de Bourgogne-Franche-Comté; ICMUB-OCS (UMR CNRS 6302); 19 avenue A. Savary BP 47870 21078 Dijon CEDEX France
| | - Raluca Malacea-Kabbara
- Institut de Chimie Moléculaire de l'Université de Bourgogne-Franche-Comté; ICMUB-OCS (UMR CNRS 6302); 19 avenue A. Savary BP 47870 21078 Dijon CEDEX France
| | - Delphine Vimont
- Department Institut des Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA-UMR CNRS 5287); 146 rue Léo Saignat 33076 Bordeaux CEDEX France
| | - Jürgen Schulz
- Department Institut des Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA-UMR CNRS 5287); 146 rue Léo Saignat 33076 Bordeaux CEDEX France
| | - Philippe Fernandez
- Department Institut des Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA-UMR CNRS 5287); 146 rue Léo Saignat 33076 Bordeaux CEDEX France
| | - Sylvain Jugé
- Institut de Chimie Moléculaire de l'Université de Bourgogne-Franche-Comté; ICMUB-OCS (UMR CNRS 6302); 19 avenue A. Savary BP 47870 21078 Dijon CEDEX France
| |
Collapse
|
10
|
Jana S, Al-huniti MH, Yang BY, Lu S, Pike VW, Lepore SD. Crown Ether Nucleophilic Catalysts (CENCs): Agents for Enhanced Silicon Radiofluorination. J Org Chem 2017; 82:2329-2335. [PMID: 28171724 PMCID: PMC5580262 DOI: 10.1021/acs.joc.6b02457] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
New bifunctional phase transfer agents were synthesized and investigated for their abilities to promote rapid fluorination at silicon. These agents, dubbed crown ether nucleophilic catalysts (CENCs), are 18-crown-6 derivatives containing a side-arm and a potentially nucleophilic hydroxyl group. These CENCs proved efficacious in the fluorination of hindered silicon substrates, with fluorination yields dependent on the length of linker connecting the metal chelating unit to the hydroxyl group. The efficacy of these CENCs was also demonstrated for rapid radiofluorination under mild conditions for eventual application in molecular imaging with positron emission tomography (PET). The hydrolysis-resistant aryl silicon fragment is promising as a convenient synthon for labeling potential PET radiotracers.
Collapse
Affiliation(s)
- Susovan Jana
- Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL 33431-0991
| | - Mohammed H. Al-huniti
- Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL 33431-0991
| | - Bo Yeun Yang
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1003
| | - Shuiyu Lu
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1003
| | - Victor W. Pike
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1003
| | - Salvatore D. Lepore
- Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL 33431-0991
| |
Collapse
|
11
|
Tao Y, Hauert R, Degen CL. Exclusively Gas-Phase Passivation of Native Oxide-Free Silicon(100) and Silicon(111) Surfaces. ACS APPLIED MATERIALS & INTERFACES 2016; 8:13157-13165. [PMID: 27153212 DOI: 10.1021/acsami.6b03326] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Reactions in the gas phase are of primary technological importance for applications in nano- and microfabrication technology and in the semiconductor industry. We present exclusively gas-phase protocols to chemically passivate oxide-free Si(111) and Si(100) surfaces with short-chain alkynes. The resulting surfaces showed equal or better oxidation resistance than most existing liquid-phase-derived surfaces and rivaled the outstanding stability of a full-coverage Si(111)-propenyl surface.1,2 The most stable surface (Si(111)-ethenyl) grew one-fifth of a monolayer of oxide (0.04 nm) after 1 month of air exposure. We monitored the regrowth of oxides on passivated Si(111) and Si(100) surfaces by X-ray photoelectron spectroscopy (XPS) and observed a significant crystal-orientation dependence of initial rates when total oxide thickness was below approximately one monolayer (0.2 nm). This difference was correlated with the desorption kinetics of residual surface Si-F bonds formed during HF treatment. We discuss applications of the technology and suggest future directions for process optimization.
Collapse
Affiliation(s)
- Ye Tao
- Department of Physics, ETH Zürich , 8093 Zürich, Switzerland
- Department of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States
| | - Roland Hauert
- Empa, Swiss Federal Laboratories of Materials Science and Technology , 8600 Dübendorf, Switzerland
| | | |
Collapse
|
12
|
Bernard-Gauthier V, Bailey JJ, Liu Z, Wängler B, Wängler C, Jurkschat K, Perrin DM, Schirrmacher R. From Unorthodox to Established: The Current Status of (18)F-Trifluoroborate- and (18)F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging. Bioconjug Chem 2015; 27:267-79. [PMID: 26566577 DOI: 10.1021/acs.bioconjchem.5b00560] [Citation(s) in RCA: 66] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Unorthodox (18)F-labeling strategies not employing the formation of a carbon-(18)F bond are seldom found in radiochemistry. Historically, the formation of a boron- or silicon-(18)F bond has been introduced very early on into the repertoire of labeling chemistries, but is without translation into any clinical radiotracer besides inorganic B[(18)F]F4(-) for brain tumor diagnosis. For many decades these labeling methodologies were forgotten and have just recently been revived by a handful of researchers thinking outside the box. When breaking with established paradigms such as the inability to obtain labeled compounds of high specific activity via isotopic exchange or performing radiofluorination in aqueous media, the research community often reacts skeptically. In 2005 and 2006, two novel labeling methodologies were introduced into radiochemistry for positron emission tomography (PET) tracer development: RBF3(-) labeling reported by Perrin et al. and the SiFA methodology by Schirrmacher, Jurkschat, and Waengler et al. which is based on isotopic exchange (IE). Both labeling methodologies have been complemented by other noncanonical strategies to introduce (18)F into biomolecules of diagnostic importance, thus profoundly enriching the landscape of (18)F radiolabeling. B- and Si-based labeling strategies finally revealed that IE is a viable alternative to established and traditional radiochemistry with the advantage of simplifying both the labeling effort as well as the necessary purification of the radiotracer. Hence IE will be the focus of this contribution over other noncanonical labeling methods. Peptides for tumor imaging especially lend themselves favorably toward one-step labeling via IE, but small molecules have been described as well, taking advantage of these new approaches, and have been used successfully for brain imaging. This Review gives an account of both radiochemistries centered on boron and silicon, describing the very beginnings of their basic research, the path that led to optimization of their chemistries, and the first encouraging preclinical results paving the way to their clinical use. This side by side approach will give the reader the opportunity to follow the development of a new basic discovery into a clinically applicable radiotracer including all the hurdles that have had to be overcome.
Collapse
Affiliation(s)
- Vadim Bernard-Gauthier
- Division of Oncological Imaging, Department of Oncology, University of Alberta , 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada
| | - Justin J Bailey
- Division of Oncological Imaging, Department of Oncology, University of Alberta , 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada
| | - Zhibo Liu
- Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health , 9000 Rockville Pike, Bethesda, Maryland 20892, United States
| | | | | | - Klaus Jurkschat
- Department of Chemistry and Chemical Biology, Technical University of Dortmund , 44227 Dortmund, Germany
| | - David M Perrin
- Department of Chemistry, University of British Columbia , 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
| | - Ralf Schirrmacher
- Division of Oncological Imaging, Department of Oncology, University of Alberta , 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada
| |
Collapse
|
13
|
Chansaenpak K, Vabre B, Gabbaï FP. [(18)F]-Group 13 fluoride derivatives as radiotracers for positron emission tomography. Chem Soc Rev 2015; 45:954-71. [PMID: 26548467 DOI: 10.1039/c5cs00687b] [Citation(s) in RCA: 80] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
The field of (18)F chemistry is rapidly expanding because of the use of this radionuclide in radiotracers for positron emission tomography (PET). Until recently, most [(18)F]-radiotracers were generated by the direct attachment of (18)F to a carbon in the organic backbone of the radiotracer. The past decade has witnessed the emergence of a new strategy based on the formation of an (18)F-group 13 element bond. This approach, which is rooted in the field of fluoride anion complexation/coordination chemistry, has led to the development of a remarkable family of boron, aluminium and gallium [(18)F]-fluoride anion complexing agents which can be conjugated with peptides and small molecules to generate disease specific PET radiotracers. This review is dedicated to the chemistry of these group 13 [(18)F]-fluorides anion complexing agents and their use in PET. Some of the key fluoride-binding motifs covered in this review include the trifluoroborate unit bound to neutral or cationic electron deficient backbones, the BF2 unit of BODIPY dyes, and AlF or GaF3 units coordinated to multidentate Lewis basic ligands. In addition to describing how these moieties can be converted into their [(18)F]-analogs, this review also dicusses their incorporation into bioconjugates for application in PET.
Collapse
Affiliation(s)
- Kantapat Chansaenpak
- Department of Chemistry, Texas A&M University, College Station, Texas 77843, USA.
| | | | | |
Collapse
|
14
|
Methods to Increase the Metabolic Stability of (18)F-Radiotracers. Molecules 2015; 20:16186-220. [PMID: 26404227 PMCID: PMC6332123 DOI: 10.3390/molecules200916186] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2015] [Revised: 08/20/2015] [Accepted: 08/26/2015] [Indexed: 11/17/2022] Open
Abstract
The majority of pharmaceuticals and other organic compounds incorporating radiotracers that are considered foreign to the body undergo metabolic changes in vivo. Metabolic degradation of these drugs is commonly caused by a system of enzymes of low substrate specificity requirement, which is present mainly in the liver, but drug metabolism may also take place in the kidneys or other organs. Thus, radiotracers and all other pharmaceuticals are faced with enormous challenges to maintain their stability in vivo highlighting the importance of their structure. Often in practice, such biologically active molecules exhibit these properties in vitro, but fail during in vivo studies due to obtaining an increased metabolism within minutes. Many pharmacologically and biologically interesting compounds never see application due to their lack of stability. One of the most important issues of radiotracers development based on fluorine-18 is the stability in vitro and in vivo. Sometimes, the metabolism of 18F-radiotracers goes along with the cleavage of the C-F bond and with the rejection of [18F]fluoride mostly combined with high background and accumulation in the skeleton. This review deals with the impact of radiodefluorination and with approaches to stabilize the C-F bond to avoid the cleavage between fluorine and carbon.
Collapse
|
15
|
Richter S, Wuest F. 18F-Labeled Peptides: The Future Is Bright. Molecules 2014; 19:20536-20556. [PMID: 25493636 PMCID: PMC6271677 DOI: 10.3390/molecules191220536] [Citation(s) in RCA: 92] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2014] [Revised: 11/24/2014] [Accepted: 11/28/2014] [Indexed: 01/10/2023] Open
Abstract
Radiolabeled peptides have been the subject of intense research efforts for targeted diagnostic imaging and radiotherapy over the last 20 years. Peptides offer several advantages for receptor imaging and targeted radiotherapy. The low molecular weight of peptides allows for rapid clearance from the blood and non-target tissue, which results in favorable target-to-non-target ratios. Moreover, peptides usually display good tissue penetration and they are generally non-immunogenic. A major drawback is their potential low metabolic stability. The majority of currently used radiolabeled peptides for targeted molecular imaging and therapy of cancer is labeled with various radiometals like 99mTc, 68Ga, and 177Lu. However, over the last decade an increasing number of 18F-labeled peptides have been reported. Despite of obvious advantages of 18F like its ease of production in large quantities at high specific activity, the low β+ energy (0.64 MeV) and the favorable half-life (109.8 min), 18F-labeling of peptides remains a special challenge. The first part of this review will provide a brief overview on chemical strategies for peptide labeling with 18F. A second part will discuss recent technological advances for 18F-labeling of peptides with special focus on microfluidic technology, automation, and kit-like preparation of 18F-labeled peptides.
Collapse
Affiliation(s)
- Susan Richter
- Department of Oncology, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.
| | - Frank Wuest
- Department of Oncology, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.
| |
Collapse
|
16
|
¹⁸F-labeled silicon-based fluoride acceptors: potential opportunities for novel positron emitting radiopharmaceuticals. BIOMED RESEARCH INTERNATIONAL 2014; 2014:454503. [PMID: 25157357 PMCID: PMC4135131 DOI: 10.1155/2014/454503] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/19/2014] [Revised: 04/07/2014] [Accepted: 04/08/2014] [Indexed: 12/16/2022]
Abstract
BACKGROUND Over the recent years, radiopharmaceutical chemistry has experienced a wide variety of innovative pushes towards finding both novel and unconventional radiochemical methods to introduce fluorine-18 into radiotracers for positron emission tomography (PET). These "nonclassical" labeling methodologies based on silicon-, boron-, and aluminium-(18)F chemistry deviate from commonplace bonding of an [(18)F]fluorine atom ((18)F) to either an aliphatic or aromatic carbon atom. One method in particular, the silicon-fluoride-acceptor isotopic exchange (SiFA-IE) approach, invalidates a dogma in radiochemistry that has been widely accepted for many years: the inability to obtain radiopharmaceuticals of high specific activity (SA) via simple IE. METHODOLOGY The most advantageous feature of IE labeling in general is that labeling precursor and labeled radiotracer are chemically identical, eliminating the need to separate the radiotracer from its precursor. SiFA-IE chemistry proceeds in dipolar aprotic solvents at room temperature and below, entirely avoiding the formation of radioactive side products during the IE. SCOPE OF REVIEW A great plethora of different SiFA species have been reported in the literature ranging from small prosthetic groups and other compounds of low molecular weight to labeled peptides and most recently affibody molecules. CONCLUSIONS The literature over the last years (from 2006 to 2014) shows unambiguously that SiFA-IE and other silicon-based fluoride acceptor strategies relying on (18)F(-) leaving group substitutions have the potential to become a valuable addition to radiochemistry.
Collapse
|
17
|
Koudih R, Kostikov A, Kovacevic M, Jolly D, Bernard-Gauthier V, Chin J, Jurkschat K, Wängler C, Wängler B, Schirrmacher R. Automated radiosynthesis of N-succinimidyl 3-(di-tert-butyl[(18)F]fluorosilyl)benzoate ([(18)F]SiFB) for peptides and proteins radiolabeling for positron emission tomography. Appl Radiat Isot 2014; 89:146-50. [PMID: 24631747 DOI: 10.1016/j.apradiso.2014.02.017] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2013] [Revised: 01/17/2014] [Accepted: 02/15/2014] [Indexed: 11/26/2022]
Abstract
Recently, silicon fluoride building blocks (SiFA) have emerged as valuable and promising tools to overcome challenges in the labeling of peptides and proteins for positron emission tomography (PET). Herein, we report a fully automated synthesis of N-succinimidyl 3-(di-tert-butyl[(18)F]fluorosilyl)benzoate ([(18)F]SiFB) by a commercially available Scintomics Hot Box 3 synthesis module, to be used as a prosthetic group for peptide and protein labeling. The drying of K2.2.2./K (18)F complex was performed according to the Munich method modified by our group (avoiding azeotropic drying) using oxalic acid to neutralize the base from the (18)F(-) containing QMA eluent. This K2.2.2./K (18)F complex was then used for SiFA (18)F-(19)F isotopic exchange followed by a fast purification by a solid-phase-extraction (SPE) to afford [(18)F]SiFB with an average preparative radiochemical yield (RCY) of 24±1% (non-decay corrected (NDC)) within a synthesis time of 30 min. The [(18)F]SiFB produced by automated synthesis was then used for the (18)F-labeling of rat serum albumin (RSA) as a proof of applicability.
Collapse
Affiliation(s)
- R Koudih
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada.
| | - A Kostikov
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada
| | - M Kovacevic
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada
| | - D Jolly
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada
| | - V Bernard-Gauthier
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada
| | - J Chin
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada
| | - K Jurkschat
- Department of Inorganic Chemistry II, Faculty of Chemistry, TU Dortmund, Otto-Hahn-Str. 6, 44221 Dortmund, Germany
| | - C Wängler
- Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany
| | - B Wängler
- Molecular Imaging and Radiopharmaceutical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany
| | - R Schirrmacher
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, Canada.
| |
Collapse
|
18
|
Al-Huniti MH, Lu S, Pike VW, Lepore SD. Enhanced Nucleophilic Fluorination and Radiofluorination of Organosilanes Appended with Potassium-Chelating Leaving Groups. J Fluor Chem 2014; 158:48-52. [PMID: 24653526 DOI: 10.1016/j.jfluchem.2013.12.005] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Here we aimed to explore the feasibility of enhancing the fluorination of organosilanes by appending potassium-chelating groups to the substrates. For this purpose, eight organosilanes were prepared in which a linear or cyclic leaving group, with putative potassium-chelating ability, was attached covalently to a congested silicon atom via an ether linkage to serve as a potential nucleophilic assisting leaving group (NALG). Organosilicon-NALGs with expected strong potassium-chelating capability enhanced reactions with potassium fluoride in acetonitrile to produce organofluorosilanes without any need to separately add phase transfer reagent. Similar rate enhancements were also observed with cyclotron-produced [18F]fluoride ion (t1/2 = 109.7 min, β+ = 97%) in the presence of potassium carbonate in MeCN-0.5% H2O. This study found that metal-chelating NALG units can accelerate fluorination and radiofluorination reactions at sterically crowded silicon atoms.
Collapse
Affiliation(s)
| | - Shuiyu Lu
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1003
| | - Victor W Pike
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1003
| | - Salvatore D Lepore
- Department of Chemistry, Florida Atlantic University, Boca Raton, Florida 33431
| |
Collapse
|
19
|
Weaver LG, Singh Y, Vamvounis G, Wyatt MF, Burn PL, Blanchfield JT. Carbohydrate globules: molecular asterisk-cored dendrimers for carbohydrate presentation. Polym Chem 2014. [DOI: 10.1039/c3py01123b] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
20
|
Dialer LO, Selivanova SV, Müller CJ, Müller A, Stellfeld T, Graham K, Dinkelborg LM, Krämer SD, Schibli R, Reiher M, Ametamey SM. Studies toward the development of new silicon-containing building blocks for the direct (18)F-labeling of peptides. J Med Chem 2013; 56:7552-63. [PMID: 23992105 DOI: 10.1021/jm400857f] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Silicon-containing prosthetic groups have been conjugated to peptides to allow for a single-step labeling with (18)F radioisotope. The fairly lipophilic di-tert-butylphenylsilane building block contributes unfavorably to the pharmacokinetic profile of bombesin conjugates. In this article, theoretical and experimental studies toward the development of more hydrophilic silicon-based building blocks are presented. Density functional theory calculations were used to predict the hydrolytic stability of di-tert-butylfluorosilanes 2-23 with the aim to improve the in vivo properties of (18)F-labeled silicon-containing biomolecules. As a further step toward improving the pharmacokinetic profile, hydrophilic linkers were introduced between the lipophilic di-tert-butylphenylsilane building block and the bombesin congeners. Increased tumor uptake was shown with two of these peptides in xenograft-bearing mice using positron emission tomography and biodistribution studies. The introduction of a hydrophilic linker is thus a viable approach to improve the tumor uptake of (18)F-labeled silicon-bombesin conjugates.
Collapse
Affiliation(s)
- Lukas O Dialer
- Center for Radiopharmaceutical Sciences of ETH, PSI and USZ, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH) Zurich , Wolfgang-Pauli Strasse 10, CH-8093, Zurich, Switzerland
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Affiliation(s)
- Annaliese K. Franz
- Department of Chemistry, University of California—Davis, One Shields Avenue, Davis,
California, United States
| | - Sean O. Wilson
- Department of Chemistry, University of California—Davis, One Shields Avenue, Davis,
California, United States
| |
Collapse
|
22
|
One-step 18F-labeling of peptides for positron emission tomography imaging using the SiFA methodology. Nat Protoc 2012; 7:1946-55. [DOI: 10.1038/nprot.2012.109] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
23
|
Kersemans K, Sablon N, Geerlings P, Mertens J. Establishment of a kinetic model for the intramolecular catalyzed hydrolysis of [18
F]-benzylfluoride containing amino acid analogues by linking experimental and DFT studies. INT J CHEM KINET 2012. [DOI: 10.1002/kin.20720] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
24
|
|
25
|
Silicon-[18F]Fluorine Radiochemistry: Basics, Applications and Challenges. APPLIED SCIENCES-BASEL 2012. [DOI: 10.3390/app2020277] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
26
|
Amigues E, Schulz J, Szlosek-Pinaud M, Fernandez P, Silvente-Poirot S, Brillouet S, Courbon F, Fouquet E. [18F]Si-RiboRGD: From Design and Synthesis to the Imaging of αvβ3 Integrins in Melanoma Tumors. Chempluschem 2012. [DOI: 10.1002/cplu.201200022] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
27
|
Kostikov AP, Chin J, Orchowski K, Niedermoser S, Kovacevic MM, Aliaga A, Jurkschat K, Wängler B, Wängler C, Wester HJ, Schirrmacher R. Oxalic acid supported Si-18F-radiofluorination: one-step radiosynthesis of N-succinimidyl 3-(di-tert-butyl[18F]fluorosilyl)benzoate ([18F]SiFB) for protein labeling. Bioconjug Chem 2012; 23:106-14. [PMID: 22148255 DOI: 10.1021/bc200525x] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
N-Succinimidyl 3-(di-tert-butyl[(18)F]fluorosilyl)benzoate ([(18)F]SiFB), a novel synthon for one-step labeling of proteins, was synthesized via a simple (18)F-(19)F isotopic exchange. A new labeling technique that circumvents the cleavage of the highly reactive active ester moiety under regular basic (18)F-labeling conditions was established. In order to synthesize high radioactivity amounts of [(18)F]SiFB, it was crucial to partially neutralize the potassium oxalate/hydroxide that was used to elute (18)F(-) from the QMA cartridge with oxalic acid to prevent decomposition of the active ester moiety. Purification of [(18)F]SiFB was performed by simple solid-phase extraction, which avoided time-consuming HPLC and yielded high specific activities of at least 525 Ci/mmol and radiochemical yields of 40-56%. In addition to conventional azeotropic drying of (18)F(-) in the presence of [K(+)⊂2.2.2.]C(2)O(4), a strong anion-exchange (SAX) cartridge was used to prepare anhydrous (18)F(-) for nucleophilic radio-fluorination omitting the vacuum assisted drying of (18)F(-). Using a lyophilized mixture of [K(+)⊂2.2.2.]OH resolubilized in acetonitrile, the (18)F(-) was eluted from the SAX cartridge and used directly for the [(18)F]SiFB synthesis. [(18)F]SiFB was applied to the labeling of various proteins in likeness to the most commonly used labeling synthon in protein labeling, N-succinimidyl-4-[(18)F]fluorobenzoate ([(18)F]SFB). Rat serum albumin (RSA), apo-transferrin, a β-cell-specific single chain antibody, and erythropoietin were successfully labeled with [(18)F]SiFB in good radiochemical yields between 19% and 36%. [(18)F]SiFB- and [(18)F]SFB-derivatized RSA were directly compared as blood pool imaging agents in healthy rats using small animal positron emission tomography. Both compounds demonstrated identical biodistributions in healthy rats, accurately visualizing the blood pool with PET.
Collapse
Affiliation(s)
- Alexey P Kostikov
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University , Montreal, QC, Canada.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Sarparanta M, Mäkilä E, Heikkilä T, Salonen J, Kukk E, Lehto VP, Santos HA, Hirvonen J, Airaksinen AJ. 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography. Mol Pharm 2011; 8:1799-806. [DOI: 10.1021/mp2001654] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Mirkka Sarparanta
- Laboratory of Radiochemistry, Department of Chemistry, University of Helsinki, FI-00014 University of Helsinki, Finland
| | - Ermei Mäkilä
- Laboratory of Industrial Physics, Department of Physics and Astronomy, University of Turku, FI-20014 University of Turku, Finland
| | - Teemu Heikkilä
- Laboratory of Industrial Physics, Department of Physics and Astronomy, University of Turku, FI-20014 University of Turku, Finland
| | - Jarno Salonen
- Laboratory of Industrial Physics, Department of Physics and Astronomy, University of Turku, FI-20014 University of Turku, Finland
| | - Edwin Kukk
- Materials Research Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014 University of Turku, Finland
| | - Vesa-Pekka Lehto
- Department of Applied Physics, University of Eastern Finland, FI-70211 Kuopio, Finland
| | - Hélder A. Santos
- Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, FI-00014 University of Helsinki, Finland
| | - Jouni Hirvonen
- Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, FI-00014 University of Helsinki, Finland
| | - Anu J. Airaksinen
- Laboratory of Radiochemistry, Department of Chemistry, University of Helsinki, FI-00014 University of Helsinki, Finland
| |
Collapse
|
29
|
Iovkova-Berends L, Wängler C, Zöller T, Höfner G, Wanner KT, Rensch C, Bartenstein P, Kostikov A, Schirrmacher R, Jurkschat K, Wängler B. t-Bu2SiF-derivatized D2-receptor ligands: the first SiFA-containing small molecule radiotracers for target-specific PET-imaging. Molecules 2011; 16:7458-79. [PMID: 21892125 PMCID: PMC6264418 DOI: 10.3390/molecules16097458] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2011] [Revised: 08/19/2011] [Accepted: 08/31/2011] [Indexed: 02/05/2023] Open
Abstract
The synthesis, radiolabeling and in vitro evaluation of new silicon-fluoride acceptor (SiFA) derivatized D(2)-receptor ligands is reported. The SiFA-technology simplifies the introduction of fluorine-18 into target specific biomolecules for Positron-Emission-Tomography (PET). However, one of the remaining challenges, especially for small molecules such as receptor-ligands, is the bulkiness of the SiFA-moiety. We therefore synthesized four Fallypride SiFA-conjugates derivatized either directly at the benzoic acid ring system (SiFA-DMFP, SiFA-FP, SiFA-DDMFP) or at the butyl-side chain (SiFA-M-FP) and tested their receptor affinities. We found D(2)-receptor affinities for all compounds in the nanomolar range (K(i(SiFA-DMFP)) = 13.6 nM, K(i(SiFA-FP)) = 33.0 nM, K(i(SiFA-DDMFP)) = 62.7 nM and K(i(SiFA-M-FP)) = 4.21 nM). The radiofluorination showed highest yields when 10 nmol of the precursors were reacted with [(18)F]fluoride/TBAHCO(3) in acetonitrile. After a reversed phased cartridge purification the desired products could be isolated as an injectable solution after only 10 min synthesis time with radiochemical yields (RCY) of more than 40% in the case of SiFA-DMFP resulting in specific activities >41 GBq/µmol (>1,100 Ci/mmol). Furthermore, the radiolabeled products were shown to be stable in the injectable solutions, as well as in human plasma, for at least 90 min.
Collapse
Affiliation(s)
- Ljuba Iovkova-Berends
- Department of Inorganic Chemistry II, Faculty of Chemistry, TU Dortmund, Otto-Hahn-Str. 6, 44221 Dortmund, Germany
| | - Carmen Wängler
- Department of Nuclear Medicine, Ludwig-Maximilians-University, Marchioninistr. 15, 81377 Munich, Germany
| | - Thomas Zöller
- Department of Inorganic Chemistry II, Faculty of Chemistry, TU Dortmund, Otto-Hahn-Str. 6, 44221 Dortmund, Germany
| | - Georg Höfner
- Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-University, Butenandtstr. 7, 81377 Munich, Germany
| | - Klaus Theodor Wanner
- Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-University, Butenandtstr. 7, 81377 Munich, Germany
| | | | - Peter Bartenstein
- Department of Nuclear Medicine, Ludwig-Maximilians-University, Marchioninistr. 15, 81377 Munich, Germany
| | - Alexey Kostikov
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University St., Montreal H3A 2B4, QC, Canada
| | - Ralf Schirrmacher
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University St., Montreal H3A 2B4, QC, Canada
| | - Klaus Jurkschat
- Department of Inorganic Chemistry II, Faculty of Chemistry, TU Dortmund, Otto-Hahn-Str. 6, 44221 Dortmund, Germany
- Authors to whom correspondence should be addressed; (K.J.); (B.W.); Tel.: +49-231-755-3800 (K.J.); +49-89-7095-7543 (B.W.); Fax: +49-231-755-5048 (K.J.); +49-89-7095-4648 (B.W.)
| | - Björn Wängler
- Department of Nuclear Medicine, Ludwig-Maximilians-University, Marchioninistr. 15, 81377 Munich, Germany
- Authors to whom correspondence should be addressed; (K.J.); (B.W.); Tel.: +49-231-755-3800 (K.J.); +49-89-7095-7543 (B.W.); Fax: +49-231-755-5048 (K.J.); +49-89-7095-4648 (B.W.)
| |
Collapse
|
30
|
|
31
|
Liu S, Liu H, Jiang H, Xu Y, Zhang H, Cheng Z. One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging 2011; 38:1732-41. [PMID: 21617974 DOI: 10.1007/s00259-011-1847-4] [Citation(s) in RCA: 72] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2011] [Accepted: 05/09/2011] [Indexed: 01/31/2023]
Abstract
PURPOSE One of the major obstacles of the clinical translation of (18)F-labeled arginine-glycine-aspartic acid (RGD) peptides has been the laborious multistep radiosynthesis. In order to facilitate the application of RGD-based positron emission tomography (PET) probes in the clinical setting we investigated in this study the feasibility of using the chelation reaction between Al(18)F and a macrocyclic chelator-conjugated dimeric RGD peptide as a simple one-step (18)F labeling strategy for development of a PET probe for tumor angiogenesis imaging. METHODS Dimeric cyclic peptide E[c(RGDyK)](2) (RGD(2)) was first conjugated with a macrocyclic chelator, 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA), and the resulting bioconjugate NOTA-RGD(2) was then radiofluorinated via Al(18)F intermediate to synthesize (18)F-AlF-NOTA-RGD(2). Integrin binding affinities of the peptides were assessed by a U87MG cell-based receptor binding assay using (125)I-echistatin as the radioligand. The tumor targeting efficacy and in vivo profile of (18)F-AlF-NOTA-RGD(2) were further evaluated in a subcutaneous U87MG glioblastoma xenograft model by microPET and biodistribution. RESULTS NOTA-RGD(2) was successfully (18)F-fluorinated with good yield within 40 min using the Al(18)F intermediate. The IC(50) of (19)F-AlF-NOTA-RGD(2) was determined to be 46 ± 4.4 nM. Quantitative microPET studies demonstrated that (18)F-AlF-NOTA-RGD(2) showed high tumor uptake, fast clearance from the body, and good tumor to normal organ ratios. CONCLUSION NOTA-RGD(2) bioconjugate has been successfully prepared and labeled with Al(18)F in one single step of radiosynthesis. The favorable in vivo performance and the short radiosynthetic route of (18)F-AlF-NOTA-RGD(2) warrant further optimization of the probe and the radiofluorination strategy to accelerate the clinical translation of (18)F-labeled RGD peptides.
Collapse
Affiliation(s)
- Shuanglong Liu
- Molecular Imaging Program at Stanford, Canary Center at Stanford for Cancer Early Detection, Bio-X Program, Department of Radiology, Stanford University, 1201 Welch Road, Lucas Expansion, P095, Stanford, CA 94305-5344, USA
| | | | | | | | | | | |
Collapse
|
32
|
Smith GE, Sladen HL, Biagini SCG, Blower PJ. Inorganic approaches for radiolabelling biomolecules with fluorine-18 for imaging with positron emission tomography. Dalton Trans 2011; 40:6196-205. [PMID: 21499604 DOI: 10.1039/c0dt01594f] [Citation(s) in RCA: 72] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Conventional methods for radiolabelling biomolecules such as proteins and peptides with fluorine-18 for PET imaging rely on carbon-fluorine bond formation and are complex and inefficient. Several non-carbon elements form strong bonds (i.e. with high bond enthalpy) with fluorine, but with lower activation energy for their formation compared to carbon-fluorine bonds, whilst preserving a relatively high kinetic stability. In particular, by incorporating boron-, aluminium- and silicon-containing prosthetic groups into biomolecules, promising results have recently been achieved in the radiolabelling with F-18-fluoride under mild aqueous conditions, affording a level of convenience, efficiency and specific activity potentially superior to those offered by conventional C-F bond formation methods. The promise already shown by these early studies heralds a new branch of bioconjugate radiochemistry involving a wider range of "fluoridephilic" elements for synthesis of PET molecular imaging agents.
Collapse
Affiliation(s)
- Gareth E Smith
- King's College London, Division of Imaging Sciences, St Thomas' Hospital, 4th Floor Lambeth Wing, London, UK SE1 7EH
| | | | | | | |
Collapse
|
33
|
Synthesis and hydrolytic stability of novel 3-[18F]fluoroethoxybis(1-methylethyl)silyl]propanamine-based prosthetic groups. J Fluor Chem 2011. [DOI: 10.1016/j.jfluchem.2011.01.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
34
|
Schulz J, Vimont D, Bordenave T, James D, Escudier JM, Allard M, Szlosek-Pinaud M, Fouquet E. Silicon-based chemistry: an original and efficient one-step approach to [18F]-nucleosides and [18F]-oligonucleotides for PET imaging. Chemistry 2011; 17:3096-100. [PMID: 21312302 DOI: 10.1002/chem.201003234] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2010] [Revised: 01/10/2011] [Indexed: 12/13/2022]
Abstract
Take it eaSi! Nucleosides, dinucleotides, and one oligonucleotide, all modified by click chemistry, have for the first time been directly and very efficiently labeled with (18)F by using a silicon-based, one-step approach that opens the way for the development of a new class of positron emission tomography (PET) tracers (see graphic).
Collapse
Affiliation(s)
- Jürgen Schulz
- Université de Bordeaux, LIMF, UMR5231, 146, rue Léo Saignat, Bordeaux, 33076, France
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Wängler C, Waser B, Alke A, Iovkova L, Buchholz HG, Niedermoser S, Jurkschat K, Fottner C, Bartenstein P, Schirrmacher R, Reubi JC, Wester HJ, Wängler B. One-Step 18F-Labeling of Carbohydrate-Conjugated Octreotate-Derivatives Containing a Silicon-Fluoride-Acceptor (SiFA): In Vitro and in Vivo Evaluation as Tumor Imaging Agents for Positron Emission Tomography (PET). Bioconjug Chem 2010; 21:2289-96. [DOI: 10.1021/bc100316c] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Affiliation(s)
- Carmen Wängler
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Beatrice Waser
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Andrea Alke
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Ljuba Iovkova
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Hans-Georg Buchholz
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Sabrina Niedermoser
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Klaus Jurkschat
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Christian Fottner
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Peter Bartenstein
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Ralf Schirrmacher
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Jean-Claude Reubi
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Hans-Jürgen Wester
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| | - Björn Wängler
- Department of Nuclear Medicine, Hospital of the Ludwig-Maximilians-University, Munich, Germany, Institute of Pathology, University of Berne, Berne, Switzerland, Department of Nuclear Medicine, Technical University Munich, Munich, Germany, Department of Inorganic Chemistry II, University of Dortmund, Dortmund, Germany, Department of Nuclear Medicine and I. Medical Clinic, University of Mainz, Germany, and McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada
| |
Collapse
|
36
|
Li Z, Conti PS. Radiopharmaceutical chemistry for positron emission tomography. Adv Drug Deliv Rev 2010; 62:1031-51. [PMID: 20854860 DOI: 10.1016/j.addr.2010.09.007] [Citation(s) in RCA: 144] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2010] [Revised: 09/11/2010] [Accepted: 09/13/2010] [Indexed: 12/13/2022]
Abstract
Molecular imaging is an emerging technology that allows the visualization of interactions between molecular probes and biological targets. Molecules that either direct or are subject to homeostatic controls in biological systems could be labeled with the appropriate radioisotopes for the quantitative measurement of selected molecular interactions during normal tissue homeostasis and again after perturbations of the normal state. In particular, positron emission tomography (PET) offers picomolar sensitivity and is a fully translational technique that requires specific probes radiolabeled with a usually short-lived positron-emitting radionuclide. PET has provided the capability of measuring biological processes at the molecular and metabolic levels in vivo by the detection of the gamma rays formed as a result of the annihilation of the positrons emitted. Despite the great wealth of information that such probes can provide, the potential of PET strongly depends on the availability of suitable PET radiotracers. However, the development of new imaging probes for PET is far from trivial and radiochemistry is a major limiting factor for the field of PET. In this review, we provided an overview of the most common chemical approaches for the synthesis of PET-labeled molecules and highlighted the most recent developments and trends. The discussed PET radionuclides include ¹¹C (t₁(/)₂=20.4min), ¹³N (t₁(/)₂=9.9min), ¹⁵O (t₁(/)₂=2min), ⁶⁸Ga (t₁(/)₂=68min), ¹⁸F (t₁(/)₂=109.8min), ⁶⁴Cu (t₁(/)₂=12.7h), and ¹²⁴I (t₁(/)₂=4.12d).
Collapse
|
37
|
Jacobson O, Chen X. PET designated flouride-18 production and chemistry. Curr Top Med Chem 2010; 10:1048-59. [PMID: 20388116 PMCID: PMC3617500 DOI: 10.2174/156802610791384298] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2009] [Accepted: 02/23/2010] [Indexed: 11/22/2022]
Abstract
Positron emission tomography (PET) is a nuclear medicine imaging technology which allows for four-dimensional, quantitative determination of the distribution of labeled biological compounds within the human body. PET is becoming an increasingly important tool for the measurement of physiological, biochemical and pharmacological functions at the molecular level in healthy and pathological conditions. This review will focus on Flouride-18, one of the common isotopes used for PET imaging, which has a half life of 109.8 minutes. This isotope can be produced with an efficient yield in a cyclotron as a nucleophile or as an electrophile. Flouride-18 can be thereafter introduced into small molecules or biomolecules using various chemical synthetic routes, to give the desired imaging agent.
Collapse
Affiliation(s)
- Orit Jacobson
- Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, 20892, USA
| | - Xiaoyuan Chen
- Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, 20892, USA
| |
Collapse
|
38
|
Design of silicon-based misonidazole analogues and 18F-radiolabelling. Nucl Med Biol 2009; 36:895-905. [DOI: 10.1016/j.nucmedbio.2009.06.004] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2009] [Revised: 06/19/2009] [Accepted: 06/24/2009] [Indexed: 11/19/2022]
|